Targeting the eicosanoid pathway in non-small-cell lung cancer
L Horn, M Backlund, DH Johnson - Expert opinion on therapeutic …, 2009 - Taylor & Francis
Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) upregulation is an early
event in the development of non-small-cell lung cancer. Preclinical data indicate tumors with …
event in the development of non-small-cell lung cancer. Preclinical data indicate tumors with …
[PDF][PDF] Targeting Eicosanoids Pathway in Non-Small Cell Lung Cancer
L Horn, M Backlund, DH Johnson - Expert Opin Ther Targets, 2009 - researchgate.net
Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) upregulation is an early
event in the development of non-small cell lung cancer. Preclinical data indicate tumors with …
event in the development of non-small cell lung cancer. Preclinical data indicate tumors with …
[HTML][HTML] Targeting Eicosanoids Pathway in Non-Small Cell Lung Cancer
L Horn, M Backlund, DH Johnson - Expert opinion on therapeutic …, 2009 - ncbi.nlm.nih.gov
Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) upregulation is an early
event in the development of non-small cell lung cancer. Preclinical data indicate tumors with …
event in the development of non-small cell lung cancer. Preclinical data indicate tumors with …
Targeting the eicosanoid pathway in non-small-cell lung cancer
L Horn, M Backlund… - Expert Opinion …, 2009 - utsouthwestern.elsevierpure.com
Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) upregulation is an early
event in the development of non-small-cell lung cancer. Preclinical data indicate tumors with …
event in the development of non-small-cell lung cancer. Preclinical data indicate tumors with …
Targeting the eicosanoid pathway in non-small-cell lung cancer.
L Horn, M Backlund, DH Johnson - Expert Opinion on Therapeutic …, 2009 - europepmc.org
Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) upregulation is an early
event in the development of non-small cell lung cancer. Preclinical data indicate tumors with …
event in the development of non-small cell lung cancer. Preclinical data indicate tumors with …
Targeting the eicosanoid pathway in non-small-cell lung cancer
L Horn, M Backlund… - Expert opinion on …, 2009 - pubmed.ncbi.nlm.nih.gov
Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) upregulation is an early
event in the development of non-small-cell lung cancer. Preclinical data indicate tumors with …
event in the development of non-small-cell lung cancer. Preclinical data indicate tumors with …
[引用][C] Targeting the eicosanoid pathway in non-small-cell lung cancer
L Horn, M Backlund, DH Johnson - Expert Opinion on Therapeutic …, 2009 - cir.nii.ac.jp
Targeting the eicosanoid pathway in non-small-cell lung cancer.
L Horn, M Backlund, DH Johnson - Expert Opinion on Therapeutic …, 2009 - europepmc.org
Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) upregulation is an early
event in the development of non-small cell lung cancer. Preclinical data indicate tumors with …
event in the development of non-small cell lung cancer. Preclinical data indicate tumors with …